Market Overview

Impax Labs Enters Commercialization Deal with Perrigo

Related PRGO
Benzinga's Top #PreMarket Losers
Markets Gather Some Momentum As Volume Remains Light, Geopolitical Tension Improving
Horizon Inks $660M Reverse Merger With Ireland's Vidara (Fox Business)
Related IPXL
Indexes Reverse Losses; Michael Kors Beats Expectations Again
Alere Drops On Downbeat Results; Trex Shares Surge

Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that it will collaborate with Perrigo Company (NASDAQ: PRGO;TASE) on the development, manufacturing and commercialization of an extended topical generic drug product with first to market potential. The product and terms of the agreement were not disclosed.

Posted-In: News

 

Related Articles (IPXL + PRGO)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters